Tyra Biosciences Inc (TYRA) Stock Analysis

Tyra Biosciences Inc (TYRA) is a publicly traded company in the HEALTHCARE sector. It trades at $28.66, carries a market capitalization of $1.86B. This page summarizes the public market data, fundamentals, and frequently asked questions for TYRA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Tyra Biosciences Inc currently has a Bullish sentiment score of 0.16.

About Tyra Biosciences Inc

Tyra Biosciences, Inc. is a preclinical-stage biopharmaceutical firm headquartered in Carlsbad, California, dedicated to innovating targeted therapies that address tumor resistance mechanisms in cancer. By leveraging its proprietary drug discovery platform, Tyra aims to enhance therapeutic efficacy and patient outcomes in oncology. The company’s focus on the development of novel compounds positions it strategically within the competitive landscape of cancer therapeutics, aiming to deliver tra...

GNG Research Analysis

GNG Research scores Tyra Biosciences Inc (TYRA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TYRA.

Frequently Asked Questions

Does TYRA pay dividends?

Tyra Biosciences Inc (TYRA) does not currently pay a regular dividend.

What is TYRA's market cap?

Tyra Biosciences Inc (TYRA) has a market capitalization of $1.86B with a current stock price of $28.66.